0001968822-23-000001.txt : 20230313 0001968822-23-000001.hdr.sgml : 20230313 20230313160438 ACCESSION NUMBER: 0001968822-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230313 DATE AS OF CHANGE: 20230313 EFFECTIVENESS DATE: 20230313 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Volastra Therapeutics, Inc. CENTRAL INDEX KEY: 0001968822 IRS NUMBER: 841816753 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-475679 FILM NUMBER: 23727295 BUSINESS ADDRESS: STREET 1: 1361 AMSTERDAM AVENUE STREET 2: SUITE 520 CITY: NEW YORK STATE: NY ZIP: 10027 BUSINESS PHONE: 646-344-1248 MAIL ADDRESS: STREET 1: 1361 AMSTERDAM AVENUE STREET 2: SUITE 520 CITY: NEW YORK STATE: NY ZIP: 10027 D 1 primary_doc.xml X0708 D LIVE 0001968822 Volastra Therapeutics, Inc. 1361 AMSTERDAM AVENUE SUITE 520 NEW YORK NY NEW YORK 10027 646-344-1248 DELAWARE None None Corporation true 2019 Charles Hugh-Jones 1361 Amsterdam Avenue Suite 520 New York NY NEW YORK 10027 Executive Officer Director Michael Su 1361 Amsterdam Avenue Suite 520 New York NY NEW YORK 10027 Executive Officer Diane Tager 1361 Amsterdam Avenue Suite 520 New York NY NEW YORK 10027 Executive Officer Sandra Peterson 1361 Amsterdam Avenue Suite 520 New York NY NEW YORK 10027 Executive Officer Director Amy Schulman 1361 Amsterdam Avenue Suite 520 New York NY NEW YORK 10027 Director Luc Dochez 1361 Amsterdam Avenue Suite 520 New York NY NEW YORK 10027 Director Samuel Bakhoum 1361 Amsterdam Avenue Suite 520 New York NY NEW YORK 10027 Director Stefan Vitorovic 1361 Amsterdam Avenue Suite 520 New York NY NEW YORK 10027 Director Biotechnology Decline to Disclose 06b false 2023-03-03 false true false 0 60174997 60174997 0 false 13 0 0 0 false Volastra Therapeutics, Inc. /s/ Charles Hugh-Jones Charles Hugh-Jones Chief Executive Officer 2023-03-13